We had an awesome oncology-themed Journal Club with Dr. Jae Sim presenting the landmark HERA trial (Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer), which was published in NEJM in 2005. This study showed significant improvement in disease-free survival among women with HER2-positive breast cancer treated with 1 year of adjuvant trastuzumab after chemotherapy.
A special thank you to our faculty discussants: Dr. Nagalla at CUH, Dr. Sadeghi at Parkland, and Dr. Dowell at the VA for leading such wonderful discussions!
Below is a summary of the questions/discussions from all 3 sites: Continue reading JC 9.18.17 – HERA trial w/ Drs. Jae Sim, Nagalla, Sadeghi, and Dowell